BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 19874177)

  • 1. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.
    Elliott JH; Vohith K; Saramony S; Savuth C; Dara C; Sarim C; Huffam S; Oelrichs R; Sophea P; Saphonn V; Kaldor J; Cooper DA; Chhi Vun M; French MA
    J Infect Dis; 2009 Dec; 200(11):1736-45. PubMed ID: 19874177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy.
    Oliver BG; Elliott JH; Price P; Phillips M; Saphonn V; Vun MC; Kaldor JM; Cooper DA; French MA
    J Infect Dis; 2010 Dec; 202(11):1728-37. PubMed ID: 20977362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
    Tan HY; Yong YK; Andrade BB; Shankar EM; Ponnampalavanar S; Omar SF; Narendran G; Kamarulzaman A; Swaminathan S; Sereti I; Crowe SM; French MA
    AIDS; 2015 Feb; 29(4):421-31. PubMed ID: 25565499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
    Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
    Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
    Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.
    da Silva TP; Giacoia-Gripp CBW; Schmaltz CA; Sant'Anna FM; Saad MH; Matos JA; de Lima E Silva JCA; Rolla VC; Morgado MG
    BMC Infect Dis; 2017 Sep; 17(1):606. PubMed ID: 28874142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.
    Worodria W; Menten J; Massinga-Loembe M; Mazakpwe D; Bagenda D; Koole O; Mayanja-Kizza H; Kestens L; Mugerwa R; Reiss P; Colebunders R;
    Antivir Ther; 2012; 17(5):841-8. PubMed ID: 22543224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
    Oliver BG; Elliott JH; Price P; Phillips M; Cooper DA; French MA
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):287-92. PubMed ID: 22732467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of TB-associated immune reconstitution inflammatory syndrome using the consensus case-definition.
    Sharma SK; Dhooria S; Barwad P; Kadhiravan T; Ranjan S; Miglani S; Gupta D
    Indian J Med Res; 2010 Jun; 131():804-8. PubMed ID: 20571170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in HIV-infected patients on antiretroviral therapy with tuberculosis.
    Tansuphasawadikul S; Saito W; Kim J; Phonrat B; Dhitavat J; Chamnachanan S; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):1053-60. PubMed ID: 18613546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
    Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
    J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
    Stephan C; Wolf T; Goetsch U; Bellinger O; Nisius G; Oremek G; Rakus Z; Gottschalk R; Stark S; Brodt HR; Staszewski S
    AIDS; 2008 Nov; 22(18):2471-9. PubMed ID: 19005270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.
    Bourgarit A; Carcelain G; Samri A; Parizot C; Lafaurie M; Abgrall S; Delcey V; Vicaut E; Sereni D; Autran B;
    J Immunol; 2009 Sep; 183(6):3915-23. PubMed ID: 19726768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
    Haddow LJ; Dibben O; Moosa MY; Borrow P; Easterbrook PJ
    AIDS; 2011 Jun; 25(9):1163-74. PubMed ID: 21505297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens.
    Vignesh R; Kumarasamy N; Lim A; Solomon S; Murugavel KG; Balakrishnan P; Solomon SS; Mayer KH; Swathirajan CR; Chandrasekaran E; Pradeep A; Poongulali S; Benson CA; French MA
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):241-8. PubMed ID: 23774879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skewing of the CD4(+) T-cell pool toward monofunctional antigen-specific responses in patients with immune reconstitution inflammatory syndrome in The Gambia.
    Wilson H; de Jong BC; Peterson K; Jaye A; Kampmann B; Ota MO; Sutherland JS
    Clin Infect Dis; 2013 Aug; 57(4):594-603. PubMed ID: 23645847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS.
    Goovaerts O; Jennes W; Massinga-Loembé M; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2014; 9(11):e113101. PubMed ID: 25415590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.